The life sciences industry encompasses pharmaceutical, biotech, and medical device companies. Due to rising costs and a greater level of complexity in bringing products to the market, this industry is experiencing more challenges. In addition, there is greater scrutiny from a regulatory perspective caused by the Affordable Care Act and the Sunshine Act, both of which have impacted the compliance obligations and visibility of the industry’s relationships with referring providers.